|
Market Cap (16-May) $717,409,856 (475th) |
Close (30-Jun) $0.056 |
Volume (30-Jun) 1,984,515 |
Shortsold (5-May) 771,706 (0.13%) (409th) |
|
52w High $2.09 |
52w Low $0.90 |
P/E - |
EPS -0.11 |
PYC released this announcement to the ASX on 27 September 2022, 8:29. The announcement is marked as price sensitive, and is 4 page(s) in length and 256.59kb in size.
You can view all announcements from PYC and see how they appear on a price chart on the announcements page.
At the date of this announcement, PYC was 0.001% short sold according to ASIC data. It was ranked the 614th most shorted stock on the ASX. It is now ranked as the 409th most shorted stock on the ASX with 0.132% of total shares short sold as of the latest reported data (05 May 2025).
| Other Recent Announcements from PYC | |
|---|---|
| FIRST PATIENT DOSED IN EYE DISEASE CLINICAL TRIAL | 30 June 2023, 8:17 |
| Change of Director's Interest Notice | 28 June 2023, 16:46 |
| PYC Investor Update Presentation | 16 June 2023, 8:32 |
| Central Nervous System Drug Program Added to PYC Pipeline | 27 September 2022, 8:29 |
| Corporate Governance Statement and Appendix 4G | 23 September 2022, 8:57 |
| Annual Report to shareholders | 23 September 2022, 8:57 |
| Preliminary Final Report | 31 August 2022, 8:53 |
You must be logged in to post a reply.
